Table VI.
Univariate analysis of prognostic factors for gastric carcinoma.
| Characteristic | Succumbed to disease (104) | Survival rate at 80 months (66) | χ2 | P-value | ||||
|---|---|---|---|---|---|---|---|---|
| Sex | ||||||||
| Male | 79 (76.0) | 48 (72.7) | 0.224 | 0.636 | ||||
| Female | 25 (24.0) | 18 (27.3) | ||||||
| Age (years) | ||||||||
| ≤60 | 58 (55.8) | 38 (57.6) | 0.054 | 0.817 | ||||
| >60 | 46 (44.2) | 28 (42.4) | ||||||
| Tumor location | ||||||||
| Cardia | 58 (55.8) | 34 (51.5) | 0.400 | 0.819 | ||||
| Body | 6 (5.8) | 5 (5.8) | ||||||
| Antrum | 40 (38.5) | 27 (40.9) | ||||||
| Tumor differentiation | ||||||||
| Poor/undifferentiated | 49 (47.1) | 30 (45.5) | 0.045 | 0.832 | ||||
| High/moderate | 55 (52.9) | 36 (54.5) | ||||||
| Tumor size | ||||||||
| <5 cm | 47 (45.2) | 27 (40.9) | 0.301 | 0.583 | ||||
| ≥5 cm | 57 (54.8) | 39 (59.1) | ||||||
| Lymphatic metastasis | ||||||||
| Negative | 15 (14.4) | 49 (74.2) | 61.549b | <0.001 | ||||
| Positive | 89 (85.6) | 17 (25.8) | ||||||
| Tumor-node-metastasis stage | ||||||||
| I–II | 14 (13.5) | 43 (65.2) | 48.404b | <0.001 | ||||
| III–IV | 90 (86.5) | 23 (34.8) | ||||||
| STIM1 expression | ||||||||
| Positive | 52 (50.0) | 22 (33.3) | 4.563a | 0.033 | ||||
| Negative | 52 (50.0) | 44 (66.7) | ||||||
Data are expressed as no. (%).
a
P<0.05
b
P<0.01. STIM1, stromal interaction molecule 1.